Peptides for Fat Loss: Which Actually Works? (2026)

How Peptides Are Studied for Fat Loss

Several classes of peptides interact with fat metabolism through distinct mechanisms. GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite centrally while improving insulin sensitivity. Growth hormone secretagogues like tesamorelin directly increase lipolysis, particularly targeting visceral fat.

Newer compounds like retatrutide act on three receptors simultaneously (GLP-1, GIP, and glucagon), combining appetite suppression with increased energy expenditure. Smaller molecules like 5-Amino-1MQ target the NNMT enzyme pathway to shift fat cell metabolism from storage to burning.

Each approach has different evidence levels, timelines, and side effect profiles — understanding the mechanisms helps in evaluating which compounds have the strongest research support for specific fat loss goals.

Peptides Studied for Fat Loss

Semaglutide

An FDA-approved weight loss injection — clinically proven for 15–20% body weight reduction.

Tirzepatide

The most powerful FDA-approved weight loss injection — up to 25% body weight reduction.

Liraglutide

An FDA-approved daily weight loss injection with the longest safety track record.

Retatrutide

A next-generation triple-action weight loss peptide — up to 24% in clinical trials.

AOD-9604

A fat loss peptide that targets stubborn fat without affecting blood sugar or growth.

5-Amino-1MQ

A fat loss compound that blocks the NNMT enzyme to boost metabolism.

Tesofensine

A weight loss compound for powerful appetite suppression and fat burning.

Cagrilintide

A next-gen amylin analog for powerful appetite control and weight loss.

Tesamorelin

An FDA-approved GHRH analog that builds lean muscle and reduces visceral belly fat.

Survodutide

A dual GLP-1/glucagon agonist for weight loss, liver fat reduction, and metabolic health.

SLU-PP-332

A small-molecule ERR receptor agonist that acts like exercise inside your cells — driving mitochondrial biogenesis, fat oxidation, and endurance gains without any actual training.

guides

Where to Buy Retatrutide: Price & Vendor Guide

One vendor sells 60mg vials at half the per-mg cost of 12mg — but COA matters more than price. Vial sizes, cost per week, and vendor scores.

Retatrutide Cycle Protocol: Length, Taper, Off-Cycle

Community sources cluster around 8-on / 8-off. Covers cycle length, week-by-week titration, tapering, off-cycle reports, and restart protocols.

SLU-PP-332 Reconstitution: Vial Mixing & Oral Cap Notes

Ion's 30 mg vial is the only injectable path. Oral caps need no mixing — but the published bioavailability question changes the math entirely.

SLU-PP-332 Dosing: 500 mcg–1.5 mg Daily SC

Community SubQ protocols run 500–1,500 mcg/day, derived from mouse-to-human dose scaling. Why oral capsules likely fail and how the math gets there.

articles

Best Peptides for Liver Health

In trials, semaglutide resolved MASH in 63% of patients — but where do BPC-157 and glutathione really stand? Every liver peptide, evidence-graded.

Boehringer's BI 3034701: New Triple-Agonist in Phase 2

Boehringer's BI 3034701, a GLP-1/GIP/NPY2 triple agonist, entered Phase 2 for obesity. How it differs from retatrutide and what buyers can get now.

Peptides for Long COVID: What the Trials Show

BPC-157, MOTS-c and microdosed GLP-1s are marketed for Long COVID while semaglutide and tirzepatide trials run. What's studied, what isn't.

KAI-7535: New Oral GLP-1 Pill Hits 11% Weight Loss

Kailera's KAI-7535 oral GLP-1 pill hit up to 11% weight loss in Phase 3 — but it's years from shelves. Here's what you can access today.

buying-guide

Where to Buy Bioglutide (NA-931): 2026 Status

Bioglutide (NA-931) isn't for sale yet — it's still in trials. See the real 2026 availability, why current listings aren't legit, and get launch alerts.

Where to Buy Survodutide: Price & Vendor Guide

BI 456906 dual agonist pricing, why 10mg vials are the norm, and what a real 4,610 Da COA proves. Vendor picks and $/mg benchmarks inside.

Where to Buy Cagrilintide: Price & Vendor Guide

Why 5mg vials suit weekly dosing, what a 3,749 Da COA must show, and per-mg pricing for the amylin analog behind CagriSema. Vendor picks inside.

Peptide Stacks Under $200/Month

4 complete peptide protocols under $200/month — fat loss, healing, anti-aging, sleep. Per-peptide cost math, vendor picks, and which vial to buy.

clinical

What Is Bioglutide (NA-931)? Oral GLP-4 Agonist

Bioglutide (NA-931): the oral quadruple agonist adding IGF-1 to retatrutide's targets. What the ADA 2025 trial data reported, and the accessible analog.

Bioglutide (NA-931) Phase 2: 13.8% Oral Weight Loss

The Phase 2 trial reported oral quadruple agonist NA-931 hit 13.8% weight loss with no muscle loss. How it stacks up to retatrutide.

Quintuple Agonist Beats Retatrutide in Rats: VRX-0075

A 5-receptor obesity peptide, VRX-0075, beat retatrutide for weight loss in obese rats at ADA 2026. What the data means and what you can buy now.

Enicepatide: Roche's CT-388 Hits 22.5% at ADA 2026

Roche's enicepatide (CT-388) hit 22.5% placebo-adjusted weight loss at ADA 2026. What the dual GLP-1/GIP data means for buyers right now.

comparison

GLP-4 vs GLP-5: Bioglutide vs VRX-0075

Bioglutide (GLP-4) adds muscle-sparing IGF-1 and has oral human data; VRX-0075 (GLP-5) adds amylin for deeper loss but is rat-only. Full comparison.

Bioglutide vs Retatrutide: Oral Quad vs Injectable

Bioglutide (NA-931) is an oral quadruple agonist; retatrutide an injectable triple. How the two obesity compounds actually compare in 2026.

SLU-PP-332 vs MOTS-c: Two Exercise Mimetics

Synthetic ERR pan-agonist vs mitochondria-encoded AMPK activator. Same goal, opposite philosophies, and the stack rationale that ties them.

Cagri+Tirz vs Cagri+Sema: Amylin Pairing Choice

REDEFINE 1 hit 22.7% with cagrilintide + semaglutide. Cagrilintide + tirzepatide has stronger GIP. Mechanistic case, trial data, and the open question.

results

Bioglutide (NA-931) Trial Results Timeline

Bioglutide (NA-931) trials reported up to 13.8% weight loss by week 13. How the oral quadruple agonist's results built across Phase 1 and Phase 2.

Tesofensine Results: Week-by-Week Timeline

Appetite suppression in days, weight loss over months. What the Phase 2 trial documented week 1 through month 6 at 0.5mg/day oral.

Survodutide Results: Week-by-Week Timeline

Appetite drops in week 1, but the 18.7% weight-loss figure took 46 weeks of titration. Full trial-reported timeline by phase and use case.

Liraglutide Results: Week-by-Week Timeline

Appetite shifts in week 1, but trial weight loss took 56 weeks. The full daily-injection timeline by phase, grounded in the SCALE trial data.

dosing

Bioglutide (NA-931) Dosage: What Trials Used

Bioglutide (NA-931) is oral, not injected. See the exact dose the Phase 2 trial used for 13.8% weight loss — and why no research-use protocol exists yet.

benefits

Bioglutide (NA-931) Benefits: Oral, No Muscle Loss

Bioglutide (NA-931) is oral, once-daily. Phase 2 subjects on 150mg/day averaged 13.8% weight loss with no muscle loss reported. What the trial data shows.

SLU-PP-332: Mice Lost 12% Body Weight in 30 Days

DIO mice on SLU-PP-332 ran 70% longer and gained 10x less fat than controls. What ERR pan-agonism does, plus the asterisks behind the data.

Retatrutide + Cagrilintide: Quad-Pathway Stack

GLP-1, GIP, glucagon, plus amylin — four metabolic axes in one stack. What the per-component trial data implies about combined effect.

Tirzepatide: 22.5% Weight Loss + Liver Fat

Weight loss gets the headlines, but tirzepatide's liver fat data may matter more. 8 research-backed effects with cited studies.

side-effects

Tesamorelin Side Effects: HIV Trial Data Breakdown

Injection-site reactions hit 25% in Phase 3. Joint pain and elevated IGF-1 follow. Full FDA-label safety breakdown.

5-Amino-1MQ Side Effects: What Research Shows

Animal models report clean safety. Community data adds mild GI and transient fatigue. Full breakdown of investigational dataset.

SLU-PP-332 Side Effects: Zero Human Data, Mouse Signals

No human Phase 1, no incidence rates. What the mouse studies and ERR receptor expression actually predict — cardiac, hepatic, and the unknown long tail.

RetaCagri Side Effects: Combined GI Burden + Dysesthesia

Both compounds slow gastric emptying via different pathways — combined nausea is the rate-limiter. Plus retatrutide's dysesthesia signal ≥9mg.

comparisons

Retatrutide vs Semaglutide: Triple vs Single Agonist

Phase 2 trials reported 24.2% weight loss for retatrutide vs 14.9% for semaglutide in STEP 1 — but only one is FDA-approved. Full side-by-side.

Liraglutide vs Semaglutide: 2.5x Weight Loss Gap

STEP 8 head-to-head: 15.8% vs 6.4% weight loss. Side-by-side dosing, side effects, and cost — and which one to actually pick.

Cagrilintide vs Semaglutide: Different Paths

They target different receptors entirely — and combining them produces 22.7% weight loss. Mechanism, efficacy, and when to use each.

stacking

SLU-PP-332 + Retatrutide Stack: Eat Less, Burn More

Triple-agonist appetite suppression + ERR pan-agonist mitochondrial output. Why community references frame it as the cleanest mechanistic pair.

bloodwork

SLU-PP-332 Bloodwork: 7 Labs Researchers Track

Lactate may be the marker that tells you if ERR pan-agonism is doing anything. Cardiac, metabolic, and liver labs published preclinical work tracked.

Tirzepatide Bloodwork: 7 Labs to Track

Most skip calcitonin — the one marker that catches the rarest but most serious risk. 7 essential labs with optimal ranges and testing schedule.

Tesamorelin Bloodwork: 7 Labs to Track

Most skip IGF-1 — the one marker that tells you if tesamorelin is actually working. 7 essential labs with optimal ranges and testing cadence.

Survodutide Bloodwork: 8 Labs to Track

Liver enzymes are the one most skip — and shouldn't with a glucagon agonist. 8 essential labs with optimal ranges and testing schedule.

industry

$30 vs $300 Semaglutide: Where the Money Goes

Same Chinese factories, 10x price gap. We break down every dollar of compounded GLP-1 markup — what's real safety value vs telehealth marketing.

reconstitution

Tesamorelin Reconstitution: 2mg + 2mL Chart

Full vial = one dose at standard concentration. Step-by-step tesamorelin mixing with dilution chart, syringe math, and storage.

weight-loss

Retatrutide vs Tirzepatide: One Clear Winner

Triple vs dual receptor agonist showdown. Retatrutide hit 24% weight loss vs tirzepatide's 22.5% — but that's not the whole story.

Price Comparisons

Compare 5-Amino-1MQ Prices

Find the best deals from trusted vendors

Compare AOD-9604 Prices

Compare Tesamorelin Prices

Compare Tesofensine Prices

Compare Tirzepatide Prices

Compare Retatrutide Prices

Compare Semaglutide Prices

Compare Survodutide Prices

Compare Cagrilintide Prices

Compare SLU-PP-332 Prices

Active Coupon Codes

Save on peptides from these verified vendors with exclusive discount codes.

Ion Peptide coupon code: 15% off

Use code thepeptidecatalog at checkout

EZ Peptides coupon code: 10% off

Ascension Peptides coupon code: 50% off

Use code THEPEPTIDECATALOG at checkout

Glacier Aminos coupon code: 10% off

Nura Peptide coupon code: 25% off

Dynamic Peptide coupon code: 10% off

Limitless Biotech coupon code: 15% off

Use code peptideinfo at checkout

BioLongevity Labs coupon code: 15% off

Swiss Chems coupon code: 10% off

Mile High Compounds coupon code: 10% off

Related Research Areas

Frequently Asked Questions

Retatrutide shows the highest weight loss in trials (28.7%), followed by tirzepatide (25%). However, GLP-1 agonists like semaglutide have more established long-term safety data. The 'best' depends on your tolerance for newer compounds versus proven track records.

Some combinations are researched (like future CagriSema), but most fat loss peptides shouldn't be stacked due to overlapping pathways. GLP-1 agonists work through similar mechanisms. A safer approach is peptides with different targets — like a GLP-1 agonist with a growth hormone secretagogue.

GLP-1 agonists typically show appetite suppression within days but significant weight loss after 4-8 weeks. Growth hormone peptides may take 8-12 weeks for body composition changes. Compounds like 5-Amino-1MQ work more gradually over 2-3 months.

Peptides like semaglutide do produce weight loss without lifestyle changes, but results are dramatically better with proper diet and exercise. They're tools that make caloric restriction easier to sustain, not replacements for healthy habits.

GLP-1 agonists reduce appetite and slow gastric emptying — you naturally eat less. Growth hormone peptides increase lipolysis (fat breakdown) and may boost metabolism. GLP-1s typically produce faster, more dramatic weight loss. GH peptides may preserve muscle better during cuts.

This page is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.